pre-IPO PHARMA

COMPANY OVERVIEW

twoXAR is an artificial intelligence-driven biopharmaceutical company. The company leverages its computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies, and progresses drug candidates to the clinic through industry partnerships.


LOCATION

  • Palo Alto, CA, USA

  • THERAPEUTIC AREAS

  • Metabolic Disorders
  • Oncology
  • Ophthalmology
  • Rare Diseases

  • WEBSITE

    https://www.twoxar.com/


    CAREER WEBSITE

    https://www.twoxar.com/company


    SOCIAL MEDIA


    INVESTORS

    andreessen-horowitz os-fund softbank-ventures


    PRESS RELEASES


    May 4, 2021

    twoXAR Pharmaceuticals Rebrands as Aria Pharmaceuticals, Provides Pipeline Update and Announces New Therapeutic Development Strategy


    Mar 4, 2021

    twoXAR Pharmaceuticals Presents Preclinical Data Showing Significant Efficacy and Safety of Two Novel Chronic Kidney Disease Treatment Candidates


    Nov 13, 2020

    twoXAR Pharmaceuticals Presents Preclinical Data Demonstrating Positive Safety and Tolerability of Two Novel NASH Treatment Candidates


    Jun 22, 2020

    twoXAR Pharmaceuticals Presents Positive Preclinical Safety and Efficacy Data for its Novel Investigational Cancer Treatment TXR-311


    Jun 3, 2020

    Howard Rosen Joins twoXAR Pharmaceuticals' Board of Directors


    For More Press Releases


    Google Analytics Alternative